Neurotech International Limited
NTI
Rank in Stocks
#26671
Neurotech International Limited (NTI.AX), along with its subsidiaries, is an... Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder. Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Share Price
$0.01176723
Last synced: 2026-11-10
Market Cap
$19.02M
Change (1 day)
6.25%
Change (1 year)
12.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neurotech International Limited (NTI)
Category
Healthcare
EPS for Neurotech International Limited (NTI)
EPS as of June 2026 TTM: $0.00
According to Neurotech International Limited's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.01, a decrease compared to its 2024 EPS of 0.00.
EPS history for Neurotech International Limited from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -69.00% |
| 2025 | $-0.01 | 81.08% |
| 2024 | 0.00 | -43.08% |
| 2023 | $-0.01 | 96.97% |
| 2022 | 0.00 | -70.80% |
| 2021 | $-0.01 | 46.75% |
| 2020 | $-0.01 | -72.98% |
| 2019 | $-0.03 | -2.06% |
| 2018 | $-0.03 | -29.71% |
| 2017 | $-0.04 | 71.78% |
| 2016 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -87,196.77% |
US
|
|
| $4.09 | -132,035.48% |
IE
|
|
| $9.45 | -304,938.71% |
US
|
|
| $2.37 | -76,551.61% |
US
|
|
| $1.77 | -57,196.77% |
US
|
Questions about Neurotech International Limited's earnings per share (EPS)
What is Neurotech International Limited's earnings per share (EPS)?
Neurotech International Limited's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Neurotech International Limited's earnings per share (EPS) in 2025?
In 2025, Neurotech International Limited's earnings per share (EPS) was $-0.01, compared with 0.00 in 2024.
How has Neurotech International Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Neurotech International Limited's earnings per share (EPS) was highest in 2024 (0.00) and lowest in 2025 ($-0.01).
How does Neurotech International Limited's earnings per share (EPS) compare with similar companies?
Neurotech International Limited's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.